Nkarta, Inc.
Nkarta develops allogeneic, off-the-shelf natural killer cell therapies for autoimmune diseases.
424B4Sep 28Latest SEC filing
Aug 10Latest story
August 2026
Sign inSign inNkarta develops allogeneic, off-the-shelf natural killer cell therapies for autoimmune diseases.